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ABSTRACT 
 
  
 
 
A  gold  screen  printed  electrode  (Au-SPE)  was  modiﬁed  by  merging  Molecular  Imprinting  and  Self- Assembly Monolayer techniques for fast 
screening cardiac biomarkers in point-of-care (POC). For this purpose,  Myoglobin  (Myo)  was  selected  as  target  analyte  and  its  plastic  antibody  
imprinted  over  a glutaraldehyde  (Glu)/cysteamine  (Cys)  layer  on  the  gold-surface.  The  imprinting  effect  was  produced by  growing  a  reticulated  
polymer  of  acrylamide  (AAM)  and  N,N∗-methylenebisacrylamide  (NNMBA) around  the  Myo  template,  covalently  attached  to  the  biosensing  surface.  
Electrochemical  impedance spectroscopy  (EIS)  and  cyclic  voltammetry  (CV)  studies  were  carried  out  in  all  chemical  modiﬁcation steps to conﬁrm the 
surface changes in the Au-SPE. 
The analytical features of the resulting biosensor were studied by different electrochemical techniques, including EIS, square wave voltammetry (SWV) 
and potentiometry. The limits of detection ranged from 
0.13 to 8 µg/mL. Only potentiometry assays showed limits of detection including the cut-off Myo levels. Quantitative information was also produced for 
Myo concentrations ≥0.2 µg/mL. The linear response of the biosensing device showed an anionic slope of ∼70 mV per decade molar concentration up to 0.3 
µg/mL. The interference of coexisting species was tested and good selectivity was observed. The biosensor   was  
successfully applied to biological ﬂuids. 
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1. Introduction 
 
Acute myocardial infarction (AMI) leads to myocardium necro- 
sis and to an increasing number of speciﬁc biomolecules ﬂowing 
in the blood and being excrete through urine,  such  as  Myo [1]. 
Myo is the ﬁrst biomolecule increasing after AMI [2–4], offering a 
high sensitive way to detect or exclude AMI conditions within 1–5 h 
of symptom onset [1]. Subsequent Myoglobinuria is also observed 
within  4–50 h [4]. 
Any intended protocol to determine Myo in POC must produce 
low turnaround times to detect such rapid biochemical alterations 
and be sufﬁciently cheap to be used routinely.  Analytical  data 
must be produced for normal/abnormal Myo ranges without 
requiring complex sample pre-treating steps. Myo cut-off levels 
range from 100–200 ng/mL [5–7]. The higher levels of Myo vary    a 
 
 
 
lot, with previous studies showing 420–2000 ng/mL in serum [8] 
and 450 ng/mL in urine [9]. 
Several methods based on enzymatic and immunoassay was 
described in the literature [10]. The ﬁrst methods for Myo determi- 
nation in blood were all supported by immunoreactions, including 
radioimmunoassay [8,11,12], counterimmunoelectrophoresis [13] 
enzyme-immunoassay [8] chemiluminescent immunoassay [14] 
and latex agglutination immunoassay [15–17], later coupled to tur- 
bidimetric [18] or nephelometric [19,20] readings and to other solid 
support materials, such as polystyrene [20]. In subsequent years 
many attempts have been made to create suitable devices for POC 
applications [21,22]. They employ various transducer principles but 
keep the immunochemical background. Immunoassays have the 
main advantage of offering a selectivity/speciﬁcity that cannot be 
matched by the chemical methods, but they lack the stability and 
the low price of these. 
A successful route to replace the immunoassays is the synthe- 
sis of plastic antibodies [23–25]. These materials are prepared by 
growing a solid polymer structure around a target compound, cre- 
ating sites that are expected to be complementary in size and 
electrostatic environment to the imprinted molecule. These  sites 
 
  
may rebind the analyte, in a similar way to that of natural antibod- 
ies. This concept has been proven successful for designing many 
biosensing devices [26], including Myo [24]. This work describes 
the surface imprinting of Myo on silica beads and its inclusion in 
PVC membranes. Myo was detected successfully, but not as low as 
cut-off levels. A previous work on surface imprinting may also be 
found, but no analytical data on the performance of the device is 
given. 
The design of Myo plastic antibodies is however a challenging 
task [27]. Protein imprinting offers several critical aspects, due to its 
complex structure and variable spatial arrangement. A successful 
plastic antibody design should meet the exact conditions under 
which the native protein exists. The use of many biocompatible 
monomeric materials, such as acrylamide and bisacrylamide that 
can be polymerized in aqueous environments, is a classical way to 
achieve such conditions [28]. On the other hand, considering that 
surface imprinting is a bottom-up approach, resembling nature’s 
processes of building complex structures, this should be the logical 
strategy for designing plastic antibodies for proteins. 
Two special requirements are needed for a successful plastic 
antibody based device for Myo determination in POC: (i) it should 
be disposable to allow a direct and easy handling [28] of biologi- 
cal ﬂuids in hospitals; and (ii) it should allow the covalent link of 
the plastic antibody to the biosensing surface, in order to ensure 
that it remains there after its contact with a liquid phase. The 
ﬁrst requirement may be achieved by using SPE technology. The 
huge developments of this ﬁeld originated a massive production 
of inexpensive, reproducible and sensitive disposable electrodes. 
The second requirement may be fulﬁlled by selecting gold sur- 
faces. Over the past decades [29], many biosensors have used 
self-assembled monolayers (SAMs) as a way to immobilize, in an 
ordered manner, organic molecules on gold surfaces [30]. This 
organic thin-ﬁlm material layer may turn out a successful and 
highly controlled way to link the imprinting layer to the gold sur- 
face. 
Therefore, the main goal of this work is to develop a biosensing 
device with plastic antibodies imprinted on Au-SPE modiﬁed by 
self-assembly for POC applications. The resulting biosensor is eval- 
uated by several electrochemical techniques and further applied to 
the analysis of biological samples. 
 
2. Experimental 
 
2.1. Apparatus 
 
The electrochemical measurements were conducted in a poten- 
tiostat/galvanostat from Metrohm Autolab/PGSTAT302 N, with a 
FRA2 module and controlled by ANOVA 7.0 software. Au-SPEs were 
purchased from DROPSENS (DRP-C220AT), having working and 
counter electrodes made of gold and reference electrode and elec- 
trical contacts made of silver. The diameter of the working electrode 
was 4 mm. 
For electrochemical assays the SPEs were place in a switch box 
from DROPSENS, interfacing the electrical contacts of the Au-SPE 
with the electrical connections of the potentiostat/galvanostat. In 
Potentiometry assays a Crison, GLP 21 pH meter (±0.1 mV sensitiv- 
ity) was used with an Ag wire covered by a layer of AgCl acting as 
reference electrode. Readings were made at room temperature  and 
sodium hydrogenophosphate dihydrate were obtained from 
Riedel Haen; potassium chloride, (hydroxymethyl)aminomethane 
(Tris) and potassium di-hydrogenphosphaste from Panreac; 2- 
(N-morpholino)ethanesulfonic acid monohydrate 98% (MES), 
from Alfa Aesar; sodium chloride, glutaraldehyde 25% (Glu), 2- 
aminoethanethiol 95% (Cys), hydrogen peroxide 30%, ethanol 
99.5%, Myo, AAM, NNMBA, ammonium persulphate (APS), oxalic 
acid (Oac), and sodium chloride from Fluka. Creatinine (Creat), 
hemoglobin (Hmg), Bovine Serum albumin (BSA), sodium gluta- 
mate (Glt) and urea were tested as interfering species and obtained 
from Fluka. 
 
2.3. Solutions 
 
Stock solutions of 5.0 × 10−6 mol/L Myo were prepared in MES 
buffer (1.0 × 10−3 mol/L, pH 4.5). Less concentrated standards were 
prepared by accurate dilution of the previous solution in buffer. 
Electrochemical assays were performed with 5.0 × 10−3 mol/L 
K3[Fe(CN)6] and K4[Fe(CN)6] in MES 1.0 × 10−3 mol/L, pH 7. The 
selectivity study used 1.0 × 10−6 mol/L Myo solutions prepared 
buffer. Solutions of interfering species were of variable concentra- 
tions and prepared in the same buffer. Creat (5.25 × 10−5 mol/L), 
Hmg      (5.0 × 10−6 mol/L),      BSA      (5.1 × 10−6 mol/L),    Glt 
(7.61 × 10−5 mol/L)  and  urea  (5.4 × 10−5 mol/L)  solutions   were 
prepared for this purpose. 
 
2.4. Design of the plastic antibody on the Au-SPE 
 
The gold surface of  the  working  electrode  was  incubated  in 
25 mmol/L ethanolic solutions of Cys for 4 h, at 25 ◦C. The result- 
ing Cys/Au-SPE was washed with distilled water and incubated for 
50 min in Glu 2.5%, prepared in 0.1 mol/L PBS, pH 7.0, at 4 ◦C. The 
Glu/Cys/Au-SPE was washed with PBS and kept in 1 × 10−6 mol/L 
Myo prepared in PBS buffer, pH 7.0, for 4 h, at 4 ◦C. The electrode was 
thoroughly washed again with PBS buffer to remove adsorbed Myo. 
The Myo/Glu/Cys/Au-SPE was then incubated in 0.5 mol/L Tris for 
30 min. and thoroughly washed with deionized water. The imprint- 
ing stage started by adding 10 µL of 1.0 mol/L AAM and 0.07 mol/L 
NNMBA, prepared in PBS, pH 7.0, to the modiﬁed gold. This was fol- 
lowed by the addition of 10 µL of 0.06 mol/L APS solution in PBS pH 
7.0. The polymerization was carried out at 25 ◦C, for 4 h. The sen- 
sor was thoroughly washed with deionized water and incubated in 
diluted Oac for 12 h. Oac is able to break peptide bonds, allowing a 
successful removal of the protein from the imprinted layer [27]. 
The imprinted sensor was washed and conditioned in 10 mmol/L 
PBS buffer, pH 7.4. 
 
2.5. AFM analysis 
 
The morphological analysis of the MIP material, before and after 
protein removal, and the negative control NIP was conducted by 
atomic force microscopy (AFM) in tapping mode. This was done in a 
Veeco Metrology Multimode/Nanoscope IVA. Nanoscope software 
was used to analyse the AFM images. 
 
2.6. Electrochemical assays 
 
CV and SWV measurements were conducted in 5.0 mmol/L of 
[Fe(CN) ]3− and 5.0 mmol/L of [Fe(CN) ]4−, prepared in MES buffer, under constant stirring. 6 6 
2.2.  Reagents 
All chemicals were of  analytical  grade  and  de-ionized 
water (conductivity <0.1 µS/cm) was employed. Potassium hex- 
acyanoferrate III, potassium hexacyanoferrate II-3-hydrate    and 
pH 7.0. For CV assays the potential was scanned from -0.5 to +0.7 V, 
at 30 mV/s. In SWV studies potentials were changed from −0.4 to 
+0.7 V, at a 0.125 V/s, corresponding to a frequency of 20 Hz and 
step height of 150 mV. 
EIS assays were conducted with the same redox couple 
[Fe(CN)6]3−/4− at a standard potential of 0.225 V, using a sinusoidal 
potential perturbation with amplitude 0.01 V (RMS) and a   number 
  
 
 
Fig. 1. Assembly of the Au-SPE imprinted device. 
 
of frequencies equal to 50, logarithmically distributed over a fre- 
quency range of 0.1–100 kHz. The impedance data were ﬁtted to a 
Randles equivalent circuit using the implemented ANOVA software. 
Potentiometric measurements were made at room temperature 
and under constant stirring, after stabilization to ±0.2 mV. Increas- 
ing concentrations of Myo were obtained by transferring   0.0100 
to 0.200 mL aliquots of 7.2 × 10−6 mol/L Myo aqueous solution to 
a 10 mL beaker containing 5.00 mL of 1.0 × 10−3 mol/L of MES, of 
ﬁxed pH and ionic strength. Between assays, the sensors were con- 
ditioned in 1.0 × 10−5 mol/L Myo solution. 
2.8.  Urine samples analysis 
 
The single standard addition method, Eq. (2), was used, where 
c0 and V0 are the unknown analyte concentration and the initial 
volume of the analyte sample, respectively [31]; c and V are the 
concentration of the standard reference solution and the volume of 
its addition; and E0  and E are the electrode potentials before and 
after adding the reference solution. The V0 and c values were 5.0 mL 
and 5 × 10−6 mol/L respectively. 
 
2.7.  Selectivity 
 
 
Potentiometric selectivity coefﬁcients were calculated by the 
Matched Potential Method (MPM), using Eq. (1). The initial con- 
centration of primary ion was set to 2.0 × 10−7 mol/L (aA) and an 
aliquot of a primary ion solution of 5.0 × 10−6 mol/L, changing the 
concentration aA∗ , was added, increasing the potential in ∼16 mV. 
The interference of Crea, Hmg, BSA, Glt, and Urea was assessed by 
adding small aliquots (aB) of the corresponding solutions (Section 
2.3) into the primary ion solution  (of  aA), until  the  same poten- 
tial change was observed, i.e., until an increment of ∼16 mV was 
reached, ensuring that the ﬁnal concentration of primary ion was 
not altered by more than 5%. 
Potentiometric analysis by single standard addition  (SAM). 
3. 
Results and discussion 
 
3.1. Design of the biosensor 
 
The working electrode of the Au-SPE was modiﬁed by following 
the scheme in Fig. 1. It consisted of six different stages, starting in 
(A) the formation of an amine layer, (B) made reactive in order to 
(C) bind the protein. The imprinting step was started by (D) self- 
organizing the monomeric structures around the template and (E) 
polymerizing with cross-linker and initiator. The imprinted sites 
were obtained (F) once the protein was   removed. 
The amine layer (Fig. 1A) was formed by incubating the gold 
surface in Cys. Its contact with a gold substrate leads to the spon- 
 POT A,B   =   taneous formation of a closely packed monolayer via a strong gold-
sulfur interaction between the    SH groups and the gold.  This 
  
monolayer has a standing-up conﬁguration with the amine groups 
( NH2) exposed to the surrounding environment. 
The external layer of primary amines was modiﬁed by    reac- 
tion with Glu (Fig. 1B). Glu carries two terminal aldehyde functions 
( CHO) to which amines react under mild conditions by means of 
a nucleophilic addition mechanism. The typical product is an imine 
( C N ), ensuring a covalent attach of Glu to the amine layer. Of 
course, the existence of two aldehyde functions in the same reac- 
tant (Glu) suggest great care in the selection of time, temperature, 
pH and concentration of Glu. One unaltered aldehyde function is 
expected to remain as an outer layer (Fig. 1B) and any deviation 
from the intended course leads to the reduction of the number 
of active carbonyls for subsequent binding of Myo. In the present 
work, the reaction took place with a diluted solution of Glu, at 4 ◦C, 
for 50 min. The pH was kept in 7.0, adjusting the surface conditions 
of the biosensor to receive a protein. 
This new aldehyde layer is ready to react with Myo (Fig. 1C). 
Myo  is  a  single  polypeptide  chain  of  153  amino  acids  carrying 
all kinds of amino acid residues. It has a globular and compact 
nature (45 × 35 × 25 A˚ ), with both polar and nonpolar amino acid 
side-chains directed to the external surface of the protein. The 
exact amount and nature of these residues are however difﬁcult 
to identify because proteins are not rigid objects as their biolog- 
ical function is controlled by conformational changes of different 
magnitudes [32]. Therefore, it is reasonable to assume  the exist- 
ence of some external function in Myo that will be able to react 
with the previous aldehyde layer. Any aliphatic amine or alcohol 
will be able to carry out this reaction. Of course the pH of this assay 
must be equal to that in physiological conditions, ensuring the same 
degree of protonation in each side-chain. The aldehyde functions 
that remained unaffected after binding Myo were blocked with Tris 
to  prevent  unexpected reactions. 
The imprinting stage started by incubating the Au-SPE with 
Myo in AAM allowing their  self-organization  around  the  pro- 
tein (Fig. 1D). NNMBA was added after, along with the initiator, 
producing a radical polymerization (Fig. 1E). The time and 
monomer/cross-linker concentrations given in this stage were of 
particular importance because if the polymer layer turns out too 
thick it may entrap the protein irreversibly. The temperature at 
which this polymerization reaction took place was also important 
because the imprinted conformation  should  match  that  of  Myo 
in the samples. Ambient temperature was selected in this stage 
considering that the sample analysis is also carried under this tem- 
perature condition. Finally, the attached protein was after removed 
later by reaction with Oac [27] to empty the imprinted sites (Fig. 1F). 
Subsequently, several washing steps were performed to remove the 
released peptide fractions from the sensory   surface. 
 
3.2. Control of the surface modiﬁcation 
 
The immobilization of organic ﬁlms on metal surfaces produces 
global modiﬁcations in the electrical features of the solid-state 
probe. This can be measured by monitoring the changes in the 
electron transfer capability of well-known redox systems, such as 
[Fe(CN)6]4−/[Fe(CN)6]3−. Indirect ways of measuring such alter- 
ations include EIS and CV [33]. 
EIS studies were used to follow the Au-SPE modiﬁcation after 
each chemical change. Randle’s equivalent circuit was adopted to 
model the physiochemical process occurring at the gold electrode 
surface (Fig. 2A), as it is often used to interpret simple electro- 
chemical systems [34]. The elements of this circuit include the 
uncompensated resistance of the solution phase (RS), the capaci- 
tance of the double layer (Cdl), and charge-transfer resistance (Rct) 
which is inversely proportional to the rate of electron transfer, and 
the Warburg diffusion element (W), accounting for the diffusion of 
ions from bulk electrolyte to the electrode interface. 
The EIS spectra of this Randle’s equivalent circuit were recorded 
for every step of the Au-SPE surface modiﬁcation and the results 
were presented as Nyquist plots (Fig. 2A). The typical plots may 
include a semicircle region lying on the real axis followed by a 
straight line. The semicircle was observed at high frequency range 
and indicated a charge-transfer controlled process. The diameter 
of this semicircle equaled the Rct controlling the electron trans- 
fer kinetics of the redox-probe at the electrode interface [35]. The 
linear range was given at the low frequency range and showed 
diffusion-controlled process from mass-transfer. 
The bare gold electrode showed a very small semicircle domain, 
suggesting a very fast electron-transfer process with a diffusional 
limiting step (Fig. 2A). The consecutive attachments of the Cys 
and Glu gave rise to subsequent increases in the electron transfer 
resistance, resulting in increases in the semicircular section of the 
Nyquist plot. The linkage of Myo followed by the polymerization 
reaction produced an additional barrier for the redox probe access 
to the Au-SPE modiﬁed electrode. This resulted in an extra increase 
in the electron transfer resistance, reﬂected by further substantial 
increase in Rct. 
CV assays are shown in Fig. 2B and supported the previous stud- 
ies of EIS. When compared to the redox probe in the bare gold, 
the subsequent modiﬁcation steps of the Au-SPE increased the 
peak-to-peak potential separation in the voltammograms, account- 
ing for the increased charge-transfer resistance. The cathodic peak 
decreased with additional modiﬁcation steps and the anodic peak 
tended to disappear, attributing a similar-to-irreversible character 
to the reaction of the redox probe. This irreversibility was curi- 
ously reversed after the polymerization step, although the anodic 
and cathodic peak currents were much lower than that of the redox 
probe on the bare gold. 
 
3.3. AFM analysis 
 
The  morphological  analysis  of  the  MIP  before  (A)  and  after 
(B) protein removal and the negative control NIP (C) was per- 
formed by AFM measurement (Fig. 3). Morphological differences 
were observed between all materials. The MIP material before 
removing the protein (A) in smother than the MIP material after 
oxalic acid treatment (B), evidencing the exit of the protein for 
the polymeric layer. Thus, the rugosity  B  may  be  attributed  to 
the vacant places created by the protein removal (and not to 
polymeric changes from the oxalic acid  treatment  because  the 
NIP surface does not a similar aspect). Furthermore,  the  “cavi- 
ties” observed in this roughness ranged ∼10 nm, suggesting that 
Myo was imprinted in monomeric or dimeric states (a single Myo 
molecule is 4.5 nm × 3.5 nm × 2.5 nm) [36]. 
 
3.4. Selection of the transducer 
 
Many biosensors in POC employ electrochemical detection as 
transducer element because of the low cost, ease of use, portabil- 
ity, and simplicity of construction [37,38]. The monitored event 
changes a speciﬁc electrical property of the electrochemical cell, 
involving, in many cases, a measurable current over a potential 
range scanning (voltammetry), a measurable charge accumulation 
or potential at near-zero current (potentiometry), or a measurable 
resistive and capacitive properties upon perturbation of a system 
by a small amplitude sinusoidal AC excitation (impedance spec- 
troscopy). These were the technical approaches taken in the present 
study. 
The calibration of the modiﬁed Au-SPE in EIS assays checked the 
effect of Myo on the charge-transfer resistance of a redox probe. 
Comparing to the spectrum of the redox probe alone, Nyquist 
plots showed that diameter of the semicircles decreased gradu- 
ally with increasing concentration of Myo. So, Myo reduced  the 
  
 
 
Fig. 2. Electrochemical controls of the subsequent modiﬁcation steps of the Au-SPE in 5.0 mM [Fe(CN)6 ]
3− and 5.0 mM [Fe(CN)6 ]
4−, in MES buffer pH 7, carried out by of EIS 
(A, Nyquist plot) and CV (B, cyclic voltammograms) assays. 
 
charge-transfer resistance of the probe once bound to the imprinted 
sensory layer (Fig. 4A). This effect was checked for a concentra- 
tion range of Myo varying from 0.16 to 48.6 µg/mL. Plots of log(Rct) 
against log[Myo] showed linear behavior from 9.0 to 36.0 µg/mL, 
with a limit of detection of 2.25 µg/mL (see Fig. 4B). 
SWV was selected among other voltammetric methods for dis- 
playing high sensitivity to surface-conﬁned electrode reactions, 
with suitable detection capabilities and rapidity. In general, the 
presence of Myo in the redox probe decreased its typical cathodic 
peak current observed without Myo by the imprinted modiﬁed 
Au-SPE (Fig. 5A). In terms of overall analytical performance, it 
was possible to observe that this effect of Myo was consistent for 
all concentrations tested, ranging from 0.16 to 48.6 µg/mL. The 
electrochemical response resulted in a negative slope calibration 
(Fig. 5B) showing a linear behavior from 9.0 to 36 µg/mL of Myo. 
The limit of detection was 8.5 µg/mL. 
Potentiometric measurements were conducted by calibrating 
the cell with Myo concentrations ranging from 0.10 to 46 µg/mL. 
 
 
 
 
Fig. 3. AFM images of: (A) MIP material before protein removal; (B) MIP material after protein removal; and (C) NIP material. AFM images obtained in tapping mode, 
300 × 300 nm scan, and processed using Nanorule program to show the 3-D topography. 
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Fig. 4. EIS Nyquist plot (A) of modiﬁed Au-SPE and the corresponding calibration curve (B) in 5.0 mM [Fe(CN)6 ]
3− and 5.0 mM [Fe(CN)6 ]
4−, in MES buffer pH 7, with different 
concentrations of Myo. 
 
Tests carried out in a pH of 7.4 were unable to produce enough 
potential changes against concentration, and other pH condi- 
tions were tested. In general, the presence of Myo in pH 4.5 
increased the potential change against concentration by decreas- 
ing the cell potential (Fig. 6). This behavior is typically attributed 
to negatively charged species, which was not as expected: Myo 
will be neutral in solutions matching its isoelectric point (7.2), 
positive in solutions of lower pH, and negative in solutions of 
higher pH. So, in a solution of pH 4.5 the net charge of Myo is 
positive. However, it is important to consider the protein great 
dimensions and its polyionic nature, carrying many positive and 
negatively-charged side chains. These conditions may imply non- 
equilibrium ion-exchange processes between the protein in the 
aqueous phase and sensory imprinted material in the solid-state 
electrode that may cause a large potential change, resulting in 
a non-equilibrium super-Nernstian response. This would be con- 
sistent with the anionic slopes of −70.3 mV/decade. Furthermore, 
the use of ammonium persulphate as initiator may attribute the 
sensory surface positive charges, repealing the negative charged 
sites of the protein and attracting the positively charged ones. 
The linear behavior was observed within 0.348 and 24 µg/mL, 
with detection limit of 0.13 µg/mL. The squared correlation coefﬁ- 
cients were always >0.992. The device also offered quick responses, 
with each standard requiring < 30 s to reach a potential stability of 
±1 mV. 
Overall, the widest linear range and the lower limit of detec- 
tion were obtained for the potentiometric assays (Table 1). In 
terms of POC applications for Myo analysis in biological ﬂuids, this 
approach was the only one reaching cut-off levels. Thus, poten- 
tiometric transduction was selected as transducer in  subsequent 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. SWV (A) of modiﬁed Au-SPE and the corresponding calibration curve (B) in 5.0 mM [Fe(CN)6 ]
3− and 5.0 mM [Fe(CN)6 ]
4−, in MES buffer pH 7, with different concentrations 
of Myo. 
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variation of 15.8 mV. The  required  concentration  was  about 
333 mg/L, corresponding to a potentiometric selectivity coefﬁcient 
of -0.77. For Crea, Glt, BSA, and Urea, the corresponding potential 
changes were only 10.3; 5.4; 0.3 and 4.8 mV, respectively. The 
corresponding concentrations were 5.84, 332, 10.2 and 3.23 mg/L, 
all below the reference levels for the intended samples. Overall, the 
selectivity study conﬁrmed the high selectivity of the potentiomet- 
ric device, suggesting its possible application under real samples. 
The stereo-selectivity of the imprinted Au-SPE was also tested 
by checking the response of Myo in a non-imprinted device, fab- 
ricated by using only PBS buffer in the step C of protein binding 
(Fig. 1). As may be seen in Fig. 5, the non-imprinted devices showed 
higher concentrations for linear ranges and detection limits with 
similar slope. Thus, the imprinting effect was observed only in the 
concentrations nearing the limit of detection. After that, Myo con- 
centration starts being too high, leading to non-speciﬁc interactions 
at the membrane-solution interface. This may turn out especially 
relevant for Myo concentrations nearing cut-off levels 
 
3.6.  Myo assay 
 
 
 
 
 
 
 
Fig. 6. Potentiometric calibration curves of MIP and NIP Au-SPE in MES buffer pH 7. 
 
 
studies, including its selectivity against other biological species and 
its behavior under practical application. 
The MIP biosensor was reused 3 times after several washes with 
buffer, and was stable for at least 3 weeks in solution. 
 
3.5. Selectivity study 
 
The selectivity of a membrane electrode is of major importance 
for a successful analytical application. It is governed mostly by the 
equilibrium that exists at the membrane-solution interface, and can 
be determined experimentally by calculating potentiometric selec- 
tivity coefﬁcients, KPOT. These coefﬁcients deﬁne the ability of an 
electrode to differentiate a primary ion from species that interfere 
in the analytical reading [39]. The lower the KPOT the smaller the 
interference. 
The matched potential method (MPM) was selected in this 
study, because it does not require that the biosensors exhibit Nern- 
stian behavior for the primary ion and interfering ions, nor that the 
ions are of equal charge (thus avoiding the difﬁculties in accuracy 
coming from the conventional methods) [39,40]. Furthermore it is 
valid and applicable to virtually any sensor as long as only small 
signal changes are considered [40]. 
The interfering species tested were selected among those that 
may be found in biological ﬂuids, such as Crea, Hmg, BSA, Glt, 
and Urea. From these, only Hmg was able to promote a potential 
 
Table 1 
Main analytical features obtained with the different electrochemical transducers. 
The standard addition method was applied to determine Myo in 
spiked urine samples, ranging from 0.48 to 0.96 µg/mL Myo. A good 
agreement was found between added and found amounts of Myo, 
with recoveries ranging 92.0 to 96.2%. Average relative standard 
deviations were 0.6%. These results pointed out the accuracy and 
the precision of the analytical data, suggesting that it may turn out 
a successful approach for screening AMI episodes in POC. 
 
4. Conclusions 
 
Surface imprinting of Myo was successfully established by 
merging self-assembled monolayer and molecular imprinting tech- 
nologies on a single Au-SPE device and applying it to Myo 
detection/determination in biological ﬂuids. Potentiometric trans- 
duction offered the best analytical features compared to EIS and 
SWV, suitable selectivity features for practical application and 
quick responses. 
Overall, the potentiometric method with the imprinted Au-SPE 
device is simple, of low cost, precise, accurate and inexpensive, and 
may turn out in a near future an alternative method for screening 
Myo in POC. 
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